Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print St. Jude identifies genomic causes of a certain type of leukemia relapse
Slashdot It! Slashdot St. Jude identifies genomic causes of a certain type of leukemia relapse
Submit to Reddit Submit St. Jude identifies genomic causes of a certain type of leukemia relapse to Reddit
Reading: St. Jude identifies genomic causes of a certain type of leukemia relapseTwitter This Reading: St. Jude identifies genomic causes of a certain type of leukemia relapseTwitter St. Jude identifies genomic causes of a certain type of leukemia relapse
Add to Facebook Add St. Jude identifies genomic causes of a certain type of leukemia relapse to Facebook

St. Jude identifies genomic causes of a certain type of leukemia relapse

December 01, 2008

New study finds the majority of acute lymphoblastic leukemia relapse cases arise from a cell already present at the time of diagnosis

Scientists at St. Jude Children's Research Hospital have identified distinctive genetic changes in the cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse. The finding offers a pathway to designing treatments for ALL relapse in children and, ultimately, in adults.




The most common childhood cancer, ALL affects thousands of children annually in the United States. Although more than 80 percent of ALL cases are cured, relapse is a significant problem, with only 30 percent of children with relapsed ALL surviving.

Previous studies had found some evidence for genetic differences between the cancer cells of ALL patients at initial diagnosis and those who relapsed. That information was limited, and there had never been a broad comparison of the entire genomes of ALL at initial diagnosis and at subsequent relapse.

In the study that appears in the Nov. 28, 2008, issue of the journal Science, St. Jude researchers compared the genomes of the cancer cells of 61 childhood ALL patients when they were initially diagnosed and after they had relapsed. The investigators used millions of genetic markers-characteristic genetic variations called single nucleotide polymorphisms-as guideposts to pinpoint genetic changes characteristic of relapsed cells. Using these genetic markers, the researchers analyzed all of the cells' chromosomes to look for genetic changes called copy number abnormalities specific to relapsed cells. These changes are considered a major type of damaging gene alterations in ALL.

"In more than 90 percent of the cases, we found differences in the genetic alterations present at the time of diagnosis and at the time of relapse," said Charles Mullighan, M.D., Ph.D., assistant member in the St. Jude Department of Pathology and the paper's first author. "Examining the new changes that are arising at relapse tells us a lot about the individual genetic lesions that might confer resistance to treatment and be responsible for relapse."

According to the researchers, the relapse-related genetic changes commonly disrupted the machinery by which white blood cells called B cells mature and proliferate. Importantly, the relapse-related genetic changes only infrequently involved genes directly regulating the responsiveness to anti-cancer drugs.

The analysis also indicated that in most cases, the cancer cells responsible for relapse were related to those that originally gave rise to the cancer. Those relapse cells were present at low levels at diagnosis, the scientists' analysis indicated. However, in a few cases, the relapse cells evolved from genetically distinct cells, indicating that the relapsed leukemia was actually an entirely new cancer.

"The key finding in our work is that in the majority of cases, relapse is arising from a cell already present at the time of diagnosis," said James Downing, M.D., St. Jude Scientific Director, chair of the Department of Pathology and the paper's senior author. "That cell is selected for during treatment and then subsequently emerges as basis for relapse."

"The second key point is that we have found a large number of new genetic alterations that had not been previously identified as new targets of copy number changes at the time of relapse," Mullighan added.

Mullighan emphasized that the findings do not mean immediate treatments for ALL relapse. "But, this is a very important starting point because we have identified several key pathways that are the most common targets of new genetic changes at the time of relapse," he said.

Identification of these relapse pathways will lead to understanding of the biological machinery of relapse, and ultimately to drugs that target that machinery. Such studies of the relapse machinery are now underway at St. Jude.

In other further studies, the researchers are also looking for other relapse-related genetic alterations besides copy number abnormalities. They are also applying their findings to adult ALL, in which relapse is a more significant problem than in the childhood disease.

St. Jude Children's Research Hospital





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Radiation   Neurological Disease   Brain Disease   OCD   Myelin   Infants   Silver   Primary Care   Anemia   Helicobacter pylori   Stem Cell Research   Folate   Cancer Death   Lung Function   Herbicide   Stress   World Trade Center   Dinosaur   Statins   Cancer Treatment   Blindness   Mars Express   Abdominal Pain   Television   Ice Core  
Related Acute Lymphoblastic Leukemia Current Events and Acute Lymphoblastic Leukemia News Articles Acute Lymphoblastic Leukemia Current Events and Acute Lymphoblastic Leukemia News RSS Acute Lymphoblastic Leukemia Current Events and Acute Lymphoblastic Leukemia News RSS
Mutant genes in high-risk childhood leukemias identified
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death.

Researchers find drug that inhibits acute leukemia cell growth
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered how to turn off a certain receptor that promotes the growth of leukemia cells.

Survey: Few physicians support private banking of umbilical cord blood
A survey of physicians has found broad support for the position that parents should not bank their newborns' umbilical cord blood in a private blood bank unless another member of the family is at risk for a blood disease that will require a stem cell transplant.

New genes involved in Acute Lymphoblastic Leukemia play fundamental role in prognosis of the disease
The inactivity or "silence" of certain genes plays a fundamental role in the prognosis of acute lymphoblastic leukemia (ALL) as well as in response to treatment, according to the results of research involving a team made up of specialists from the University Hospital of Navarra and the Centre for Applied Medical Research (CIMA) at the same University of Navarra, as well as the Reina Sofía Hospital in Córdoba, Andalusia.

Novel treatments show improvements in survival and response rates for leukemia and lymphoma
The use of dexamethasone early in the treatment of children with acute lymphoblastic leukemia, the most common type of childhood cancer, may help reduce the risk of relapse.

St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia
The first analysis of the genetic determinants of resistance to the anti-cancer drug methotrexate in childhood acute lymphoblastic leukemia (ALL) could offer a pathway to predicting such resistance and treatments to overcome it, according to a St. Jude Children's Research Hospital study.

St. Jude discovery offers new avenues to understanding an aggressive form of leukemia
Researchers at St. Jude Children”¦s Research Hospital have discovered evidence that a series of genetic mutations work together to initiate most cases of an aggressive and often-fatal form of acute lymphoblastic leukemia (ALL).

Childhood leukemia survivors struggle with long-term comorbidities
Survival rates of childhood cancers, especially leukemia, have improved greatly in the past three decades, but survivors of this disease still seem to face many health and lifestyle challenges as young adults.

Molecular science could further improve leukemia survival, say St. Jude researchers
The dramatic increase that has occurred in the cure rate for children with acute lymphoblastic leukemia (ALL) will be difficult to replicate in older patients without considerable additional research.

Ireland Cancer Center researchers advance stem cell gene therapy
Ireland Cancer Center of University Hospitals Case Medical Center researchers have recently made great strides in stem cell gene therapy research by transferring a new gene to cancer patients, via their own stem cells, with the ultimate goal of being able to use stronger chemotherapy treatment with less severe side effects.
More Acute Lymphoblastic Leukemia Current Events and Acute Lymphoblastic Leukemia News Articles
The Official Parent's Sourcebook on Childhood Acute Lymphoblastic Leukemia

The Official Parent's Sourcebook on Childhood Acute Lymphoblastic Leukemia
by James N., M.D. Parker (Editor), Philip M. Parker (Editor)

This book has been created for parents who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells parents where and how to look for information covering virtually all topics related to childhood acute lymphoblastic leukemia (also Acute childhood leukemia; Acute lymphocytic leukemia; Cancer acute childhood leukemia; Lymphoid leukemia; Tumor adrenal), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest...

Fight Against Acute Lymphoblastic Leukemia Sweatshirt Medium White

Fight Against Acute Lymphoblastic Leukemia Sweatshirt Medium White



Beating Acute Lymphoblastic Leukemia Together Mug

Beating Acute Lymphoblastic Leukemia Together Mug
by Design a Product LLC

Text on mug: Beating Acute Lymphoblastic Leukemia Together
* Custom coffee mugs are dishwasher-safe and microwave-safe. Colors are permanently baked into the mug''s surface.
* If you have new ideas or need help selecting text for your custom coffee mugs please contact us.
* Size: 11 oz. capacity ceramic coffee mug.

Can We Cure the Common Leukemias?

Can We Cure the Common Leukemias?



Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation
by Humana Press

Remarkable developments in the field of transplantation have created opportunities to address the formidable challenges of transplantation across histocompatibility barriers, stem cell expansion, and prevention of complications and generation of graft-vs-tumor activity to eradicate residual disease. "Stem Cell Transplantation for Hematologic and Other Disorders, Second Edition" provides a glimpse into potential future applications of bone marrow derived stem cells in the field of cardiac repair. The updated chapters introduce the biologic underpinnings of hematopoietic cell transplantation, basic stem cell biology, immunobiology, and histocompatibility, with emphasis on indications and results of transplantation for specific diseases. Written by experts in the field, "Stem Cell...

The Official Patient's Sourcebook on Adult Acute Lymphoblastic Leukemia: A Revised and Updated Directory for the Internet Age

The Official Patient's Sourcebook on Adult Acute Lymphoblastic Leukemia: A Revised and Updated Directory for the Internet Age
by ICON Health Publications (Author)

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to adult acute lymphoblastic leukemia (also acute lymphoblastic leukemia; lymphoblastic leukemia; Lymphoid leukemia), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on adult...

  Chromosomes and Genes in Acute Lymphoblastic Leukemia (Medical Intelligence Unit)
by Lorna M. Secker-Walker (Author)

G. Landes). Royal Free Hospital, London, U.K. Research describing the large number of chromosome changes reported in acute lymphoblastic leukemia. DNLM: Leukemia, Lymphocytic, Acute--genetics.

Cure Acute Lymphoblastic Leukemia Long Sleeve T-shirt Large White

Cure Acute Lymphoblastic Leukemia Long Sleeve T-shirt Large White



Cure Acute Lymphoblastic Leukemia Keychain

Cure Acute Lymphoblastic Leukemia Keychain
by Design a Product LLC

Text on keychain: Cure Acute Lymphoblastic Leukemia
* Durable acrylic key chain is crystal-clear and double-sided so the artwork or message is seen twice.
* Sturdy metal ring holds your keys securely.
* Full color printed images or messages are included.
* If you have new ideas or need help selecting text for your custom keychains please contact us.
* Size: 2 1/8" x 3 1/2" (Approx. business card)

Leukemia: Acute myeloid leukemia, Acute lymphoblastic leukemia,  Chronic myelogenous leukemia, Lymphoid leukemia, Myeloid  leukemia

Leukemia: Acute myeloid leukemia, Acute lymphoblastic leukemia, Chronic myelogenous leukemia, Lymphoid leukemia, Myeloid leukemia
by John McBrewster (Editor), Frederic P. Miller (Editor), Agnes F. Vandome (Editor)

Leukemia (British English: leukaemia) (Greek leukos ?e????, "white"; aima a?µa, "blood") is a cancer of the blood or bone marrow and is characterized by an abnormal proliferation (production by multiplication) of blood cells, usually white blood cells (leukocytes). Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader group of diseases called hematological neoplasms. Leukemia is clinically and pathologically subdivided into several large groups.

© 2009 BrightSurf.com